PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.

Abstract Pathomorphological study of trephinobiopsy specimens from 129 patients with lymphoproliferative and myeloproliferative diseases was carried out over the course of chemotherapy. Combinations of initial and manifest myelofibrosis (loose network of reticulin fibers and extensive network of reticulin and collagen fibers, respectively) predominated at the debut of chronic myeloid leukemia, chronic lymphoid leukemia, and multiple myeloma. Manifest myelofibrosis was detected in patients with chronic myeloid leukemia without hematological response (failure of normalization of hematological values) and in patients with progressing and relapsing multiple myeloma. Combinations of foci of initial and manifest myelofibrosis were most incident in patients with progressing and relapsing chronic lymphoid leukemia. The incidence of myelofibrosis was higher in patients with multiple myeloma and chronic lymphoid leukemia progression and relapses and in patients with chronic myeloid leukemia without hematological response than at the disease debut and in case of response to chemotherapy. The response to chemotherapy in patients with chronic myeloid leukemia and chronic lymphoid leukemia was associated with a decrease in the incidence of myelofibrosis. In patients with multiple myeloma responding to chemotherapy, the incidence of myelofibrosis did not change in comparison with the disease debut.
PMID
Related Publications

Uncommon case of chronic myeloid leukemia with multiple myeloma.

Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.

The combination of chronic myeloid leukemia and multiple myeloma in one patient.

Clinical Morphological Studies of Myelofibrosis with Different Types of Bone Marrow Involvement in Patients with Chronic Lymphocytic Leukemia.

Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha.

Authors

Mayor MeshTerms
Keywords

chronic lymphoid leukemia

chronic myeloid leukemia

multiple myeloma

myelofibrosis

trephinobiopsy specimens

Journal Title bulletin of experimental biology and medicine
Publication Year Start




PMID- 28239786
OWN - NLM
STAT- MEDLINE
DA  - 20170227
DCOM- 20170315
LR  - 20170315
IS  - 1573-8221 (Electronic)
IS  - 0007-4888 (Linking)
VI  - 162
IP  - 4
DP  - 2017 Feb
TI  - Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and
      Chronic Lymphoid Leukemia during Various Phases of Diseases.
PG  - 483-487
LID - 10.1007/s10517-017-3645-x [doi]
AB  - Pathomorphological study of trephinobiopsy specimens from 129 patients with
      lymphoproliferative and myeloproliferative diseases was carried out over the
      course of chemotherapy. Combinations of initial and manifest myelofibrosis (loose
      network of reticulin fibers and extensive network of reticulin and collagen
      fibers, respectively) predominated at the debut of chronic myeloid leukemia,
      chronic lymphoid leukemia, and multiple myeloma. Manifest myelofibrosis was
      detected in patients with chronic myeloid leukemia without hematological response
      (failure of normalization of hematological values) and in patients with
      progressing and relapsing multiple myeloma. Combinations of foci of initial and
      manifest myelofibrosis were most incident in patients with progressing and
      relapsing chronic lymphoid leukemia. The incidence of myelofibrosis was higher in
      patients with multiple myeloma and chronic lymphoid leukemia progression and
      relapses and in patients with chronic myeloid leukemia without hematological
      response than at the disease debut and in case of response to chemotherapy. The
      response to chemotherapy in patients with chronic myeloid leukemia and chronic
      lymphoid leukemia was associated with a decrease in the incidence of
      myelofibrosis. In patients with multiple myeloma responding to chemotherapy, the 
      incidence of myelofibrosis did not change in comparison with the disease debut.
FAU - Dolgikh, T Yu
AU  - Dolgikh TY
AD  - Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia.
      pathol@inbox.ru.
FAU - Domnikova, N P
AU  - Domnikova NP
AD  - Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia.
FAU - Tornuev, Yu V
AU  - Tornuev YV
AD  - Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia.
FAU - Vinogradova, E V
AU  - Vinogradova EV
AD  - Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia.
FAU - Krinitsyna, Yu M
AU  - Krinitsyna YM
AD  - Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia.
LA  - eng
PT  - Journal Article
DEP - 20170227
PL  - United States
TA  - Bull Exp Biol Med
JT  - Bulletin of experimental biology and medicine
JID - 0372557
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Bone Marrow/drug effects/*pathology
MH  - Chronic Disease
MH  - Disease Progression
MH  - Female
MH  - Humans
MH  - Leukemia, Lymphoid/*complications/diagnosis/drug therapy/pathology
MH  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*complications/diagnosis/drug
      therapy/pathology
MH  - Male
MH  - Middle Aged
MH  - Multiple Myeloma/*complications/diagnosis/drug therapy/pathology
MH  - Neoplasm Staging
MH  - Primary Myelofibrosis/*complications/diagnosis/drug therapy/pathology
MH  - Prospective Studies
OTO - NOTNLM
OT  - chronic lymphoid leukemia
OT  - chronic myeloid leukemia
OT  - multiple myeloma
OT  - myelofibrosis
OT  - trephinobiopsy specimens
EDAT- 2017/02/28 06:00
MHDA- 2017/03/16 06:00
CRDT- 2017/02/28 06:00
PHST- 2015/07/20 [received]
AID - 10.1007/s10517-017-3645-x [doi]
AID - 10.1007/s10517-017-3645-x [pii]
PST - ppublish
SO  - Bull Exp Biol Med. 2017 Feb;162(4):483-487. doi: 10.1007/s10517-017-3645-x. Epub 
      2017 Feb 27.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>